Newmarket Strategy

🚨The Data Use and Access Bill - New Data Laws Set to Transform UK Services & Economy🚨 The Data Use and Access Bill, introduced to the UK Parliament, aims to modernise the country’s data policies to foster more effective data sharing and use across various sectors, particularly public services. Rooted in objectives to stimulate economic growth and optimise public service delivery, this legislation introduces significant shifts in data access, aiming to generate up to £10 billion for the UK economy by easing data flow across public, private, and healthcare sectors to streamline and clarify data-sharing practices by enhancing lawful access provisions, with healthcare as a core area of focus. The bill is presented as part of the UK Government’s post-Brexit vision to establish a flexible data regime independent from the EU’s General Data Protection Regulation (GDPR), aiming to strike a balance between innovation and privacy protections. To read more about the Bill, please follow the link below: https://lnkd.in/eK_EMh_a #DataAccess #UKEconomy #DigitalTransformation

Newmarket Strategy are delighted to announce that Tirenioluwa K. has joined as a Senior Consultant in the Digital Health and Research team. With over five years of experience in market access and pricing strategy within biopharma and various healthcare settings, she is committed to driving solutions that enhance patient care and improve health outcomes.   Tireni is a market access and pricing specialist dedicated to accelerating the availability of innovative therapies across the UK and Europe. With a unique background as both a nurse and a health economist, she brings valuable insights into the impact of innovations on patients and healthcare systems.   Tireni holds an MSc in Health Economics from the University of Galway and a BSc in General Nursing from the University College Dublin.

Our Founder and Senior Partner, Ed Jones, spoke at the 2024 HealthInvestor Healthcare Summit last week. With an audience of private equity and industry, the panel discussed the way changes in policy and strategy from the new Government will impact partnerships and business models within the NHS. To see more, please follow the link: https://lnkd.in/eUdfQWhT #HealthCare #Investment #FutureofHealthcare

Our Senior Partner, Ed Jones, chaired a panel at the IHEEM (The Institute of Healthcare Engineering and Estate Management) Healthcare Estates conference in Manchester this month. Featuring offsite construction experts Merit, the discussion focussed on how technology and innovation can enable more sustainable healthcare facilities. To see more, please follow the link: https://lnkd.in/eHZ6JjM #Healthcare #SmartHospitals #HealthcareTech

🚨 British Medical Association GP Committee votes to phase out physician associates 🚨 The British Medical Association (BMA) has announced that its general practitioners' (GPs) committee has voted in favour of phasing out the role of physician associates (PAs) in general practice, citing concerns over patient safety. The motion, backed by an majority of committee members, calls for no new PA appointments and for their current involvement in managing undifferentiated patients to be immediately suspended. PAs are healthcare professionals with a generalist education who assist doctors in diagnosing and managing patients. Currently, there are around 2,000 PAs working in general practice across the UK. However, the BMA suggests that those already in these roles should be offered opportunities to retrain and transition into other NHS positions. Dr Katie Bramall-Stainer, chair of the BMA’s GPs committee, acknowledged the political sensitivity of the issue but stressed that patient safety must come first, alongside the responsibility of practices to ensure that their staff are suitably trained and competent to see patients without supervision. The decision follows a recent move by the Royal College of General Practitioners, whose governing council voted to oppose the PA role in general practice. The College also issued guidance for practices that already employ PAs. To read more, please use the link below: https://lnkd.in/gveY94yb #NHS #Healthcare

🌍 NHS Waste Reduction: A Step Toward a Sustainable Future ♻️   The UK Government has launched the “Design for Life” strategy aimed at reducing waste within the NHS by focusing on sustainable alternatives to single-use medical devices. One hospital has already saved £20,000 annually by switching to reusable tourniquets.   Beyond financial savings, embracing a circular economy in healthcare could contribute £75 billion to the UK economy and create 500,000 jobs by 2030. This initiative highlights the importance of sustainability in the healthcare sector and the significant benefits it can bring.   To read more, please use the link below: https://lnkd.in/gbSTEKET   #Sustainability #NHS #WasteReduction #Healthcare

💡 NHS Introduces Groundbreaking Priority System for High-Risk Liver Transplants 💡   The NHS has implemented a world-first priority system for liver transplants, targeting patients with acute-on-chronic liver failure (ACLF)—a condition with a staggering 70% mortality rate. This new system will give hope to patients who previously had little chance of survival.   During the pilot, 77% of ACLF patients who received transplants were alive one year after surgery, compared to a 100% fatality rate for those who didn’t undergo the procedure. This initiative has now become standard practice across the UK and is being reviewed for potential adoption in other countries.   A major step forward in improving patient outcomes!   To read more, please use the link below: https://lnkd.in/eggk2pXv   #NHSInnovation #LiverTransplants #HealthcareBreakthrough #PatientCare

🖥🔬Health Tech for Cancer to Get Funding Boost 🔬🖥 Exciting advancements in cancer diagnosis and treatment are coming to the UK, thanks to new public and private sector partnerships. The UK government, alongside industry partners, has announced significant investments to trial cutting-edge medical technologies, including AI-driven diagnostic tools and advanced scanners. Backed by £6.4 million for a new AI digital pathology data platform, researchers will gain easier access to NHS data, accelerating the development of next-generation treatments. This follows Lord Darzi’s review highlighting the UK's lagging cancer survival rates. Additionally, UK Research and Innovation unveiled a £118 million fund to create five health technology hubs, including innovations in cancer imaging and wearable devices for mobility. These developments aim to detect cancers earlier and improve surgical outcomes, while supporting Britain’s life sciences sector. The initiative underscores the government’s commitment to leveraging science and innovation to combat cancer and other diseases, while fostering the UK’s position as a leader in medical technology. As noted by NHS leaders and government officials, these investments will save lives and drive economic growth, positioning the UK at the forefront of medical advancements. To read more, please use the link below: https://lnkd.in/ed5AzQ98 #Innovation #AIinHealthcare #LifeSciences #CancerResearch #HealthcareTransformation

🥇 New Nobel Laureates Named for Physiology or Medicine 🥇 Prof. Victor Ambros and Prof. Gary Ruvkun have been awarded the 2024 Nobel Prize in Physiology or Medicine for their discovery of microRNA; molecules crucial for gene regulation. Their groundbreaking work, published in 1993, initially focused on the roundworm Caenorhabditis elegans and was met with scepticism. However, in 2000, Ruvkun's team showed that microRNAs are present across the animal kingdom, including humans. Since then, hundreds of microRNAs have been identified, with over a thousand genes for microRNAs in humans alone, and they are recognised as vital for gene regulation in multicellular organisms. MicroRNAs are now linked to heart disease, viral infections, and neurological disorders, with therapies targeting them undergoing clinical trials for various diseases. Prof. Ambros and Prof. Ruvkun share a prize fund of 11 million Swedish kronor ($1.1 million). The Nobel ceremony will be held on December 10th in Stockholm. To read more, please use the link below: https://lnkd.in/eCYJmr-6 #NobelPrize #miRNA #HealthInnovation

Take a look at our new blog post - The value of commercial clinical trials. You can read the article here: https://lnkd.in/e7Ay-nDd #CommercialClinicalTrials #UKEconomy #NHS